For instance, tumor-derived exosomes contain soluble NKG2D ligands and TGF-β, which can inhibit the surface NKG2D expression and reduce NKG2D-dependent cytotoxicity on NK cells and CD8+ T cells [34]. This evidence concerns the gene TGFB1 and neoplasm.